Evidence map›Paper›PMID 23530149›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages.

Jessica J Ashbaugh, Roberta Brambilla, Shaffiat A Karmally, Cecilia Cabello, Thomas R Malek, John R Bethea

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. IL-7Rα on CD4Journal of neuroinflammation · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Article
  11. Article
  12. Genetic determinants of risk and progression in multiple sclerosis.Clinica chimica acta; international journal of clinical chemistry · 2015
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jessica J AshbaughDepartment of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Roberta Brambilla
Shaffiat A Karmally
Cecilia Cabello
Thomas R Malek
John R Bethea
University of Miami · US

Funding

TNF in Injury and Repair Processes Following Traumatic SCIR01NS051709 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI John Roland Bethea · 2005 to 2026
$8.0M
PREDOCTORAL TRAINING PROGRAM IN THE NEUROSCIENCEST32NS007492 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BIXBY, JOHN L · 2001 to 2010
$1.8M
Astrocytes Play a Critical Role in the Pathology of EAER01NS065479 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BETHEA, JOHN ROLAND · 2009 to 2013
$1.6M
NINDS NIH HHS 5-R01-NS065479-03NINDS NIH HHS 5-T32-NS007492-08NINDS NIH HHS R01 NS051709NINDS NIH HHS R01 NS065479NINDS NIH HHS T32 NS007492
6 · The paper itself

Abstract

A mutation in the IL7Rα locus has been identified as a risk factor for multiple sclerosis (MS), a neurodegenerative autoimmune disease characterized by inflammation, demyelination, and axonal damage. IL7Rα has well documented roles in lymphocyte development and homeostasis, but its involvement in disease is largely understudied. In this study, we use the experimental autoimmune encephalomyelitis (EAE) model of MS to show that a less severe form of the disease results when IL7Rα expression is largely restricted to thymic tissue in IL7RTg(IL7R-/-) mice. Compared with wild-type (WT) mice, IL7RTg(IL7R-/-) mice exhibited reduced paralysis and myelin damage that correlated with dampened effector responses, namely decreased TNF production. Furthermore, treatment of diseased WT mice with neutralizing anti-IL7Rα Ab also resulted in significant improvement of EAE. In addition, chimeric mice were generated by bone marrow transplant to limit expression of IL7Rα to cells of either hematopoietic or nonhematopoietic origin. Mice lacking IL7Rα only on hematopoietic cells develop severe EAE, suggesting that IL7Rα expression in the nonhematopoietic compartment contributes to disease. Moreover, novel IL7Rα expression was identified on astrocytes and oligodendrocytes endogenous to the CNS. Chimeric mice that lack IL7Rα only on nonhematopoietic cells also develop severe EAE, which further supports the role of IL7Rα in T cell effector function. Conversely, mice that lack IL7Rα throughout both compartments are dramatically protected from disease. Taken together, these data indicate that multiple cell types use IL7Rα signaling in the development of EAE, and inhibition of this pathway should be considered as a new therapeutic avenue for MS.

Indexed as

AnimalsAstrocytesBone Marrow TransplantationCell LineageCentral Nervous SystemCytokinesEncephalomyelitis, Autoimmune, ExperimentalFemaleLymphocyte ActivationMaleMiceMice, Inbred C57BLMultiple SclerosisMutationMyelin SheathOligodendrogliaCytokinesinterleukin-7 receptor, alpha chainReceptors, Interleukin-7Tumor Necrosis Factor-alpha

Identifiers

PMID23530149
PMCPMC4120889
OpenAlexW2136823896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.